Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma

BACKGROUND: In experimental systems, interference with coagulation can affect tumor biology. We suggested that abnormal coagulation could be a negative predictor for response to immunotherapy and survival among patients with metastatic renal cell carcinoma (MRCC). METHODS: To address this issue, ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsimafeyeu, Ilya V, Demidov, Lev V, Madzhuga, Albina V, Somonova, Oksana V, Yelizarova, Anna L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654863/
https://www.ncbi.nlm.nih.gov/pubmed/19254383
http://dx.doi.org/10.1186/1756-9966-28-30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2654863/
https://www.ncbi.nlm.nih.gov/pubmed/19254383
http://dx.doi.org/10.1186/1756-9966-28-30

Ejemplares similares